A recently approved Biogen Alzheimer’s drug, Aduhelm® (Aducanumab), raises questions about the ethics of a laissez-faire, profit-driven medical industry. Despite the Food & Drug Administration’s
The accelerated approval of Biogen’s Alzheimer’s drug, Aduhelm®, has been controversial, in part due to its significant side effects. Aduhelm was proven to significantly increase
The C.R. Bard bellwether hernia mesh trial is scheduled to commence this week. This is a significant week for our Bard hernia mesh clients whose
Both Neutragena and Aveeno have pulled some of their sunscreen products from the shelves due to high levels of the toxic chemical benzene. The companies
With civil lawsuits pending against dioceses and archdioceses where he worked, former Cardinal Theodore McCarrick will now face criminal charges for alleged sexual abuse of
Alex Gorsky, the CEO of one of the world’s largest pharmaceutical companies Johnson & Johnson, is stepping down in January 2022 after 30 years with
NY State Attorney General has completed her office’s investigation of NY Governor Andrew Cuomo concerning sexual harassment allegations lodged against him from current and former
Specialists Losing Trust in FDA Following Alleged Unbiasedness in New Drug Approval Process According to a survey conducted by independent market research firm Spherix Global Insights, over
